ndex.html" onclick="linkClick( this.href );" target="_blank" title="Symmetric Computing">Symmetric Computing is a Massachusetts-based high-performance computing start-up company developing advanced supercomputing at breakthrough performance and price for the life sciences industry. The firm seeks collaborations with UMass Boston scientists and will offer internships to UMass Boston computer science students.
"I want to congratulate UMass Boston on the opening of the new Venture Development Center. The spirit of discovery and innovation is the backbone of this new facility," Mayor Thomas M. Menino said. "Not only will it attract start-up biotech, life sciences, and other research initiatives to right here in Dorchester, it will also generate spin-off economic development benefits for Boston and the surrounding neighborhoods."
In addition to the current partners, the Venture Development Center is working to launch the Center for Personalized Cancer Therapy with Dana-Farber/Harvard Cancer Center later this year. The center will work to develop affordable diagnostic tests that match a disease with therapy for community hospitals.
About UMass Boston
With a growing reputation for innovative research addressing complex urban issues, the University of Massachusetts Boston, metropolitan Boston's only public university, offers its diverse student population both an intimate learning environment and the rich experience of a great American city. UMass Boston's seven colleges and graduate schools serve more than 14,000 students while engaging local, national, and international constituents through academic programs, research centers, and public service activities. To learn more about UMass Boston, visit www.umb.edu.
About the Venture Development Center
The Venture Development Center is the strategic business development
Page: 1 2 3 4 Related biology technology :1
Copyright©2009 Vocus, Inc.
All rights reserved
. Boston Scientific Announces First Quarter Special Items2
. Boston Scientific Launches New Coronary Imaging Catheter3
. Moodys Raises Boston Scientifics Rating Outlook to Stable4
. BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University5
. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston6
. Boston LASIK Eye Surgery Expert Dr. Peter Rapoza Joins Select Group of Doctors in Trusted LASIK Surgeons Directory7
. Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge8
. Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System9
. Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor10
. Boston Scientific Acquires Labcoat Limited11
. FDA Approves Boston Scientifics Express(R) SD Renal Stent System